• About Us
  • Our Mission
  • Park Team
  • Board of Directors
  • Publications
• Discovery Park
  • Facilities
  • Leasing Inquiries
  • Tenant Listing
  • Tenant Information
  • Tenant Request Form
• Advanced Manufacturing Park
  • Facilities
  • Leasing Inquiries
  • Tenant Listing
• Sarnia-Lambton Research Park
  • Facilities
  • Leasing Inquiries
• News and Events
  • Events
  • News

• MENU
  • About Us
  • Discovery Park
  • Advanced Manufacturing Park
  • Sarnia-Lambton Research Park
  • News and Events

• Home
• News and Events
• News

News

March 18, 2021

London biotech firm wins $23M investment for new diabetes treatment


March 10, 2020

ENDRA Life Sciences Receives CE Mark for its TAEUS® Clinical Product Targeting Non-Alcoholic Fatty Liver Disease


March 06, 2020

ENDRA Life Sciences Granted Chinese Patent for "Thermoacoustic Imaging Probe"


March 03, 2020

Dr. Raza Malik joins ENDRA Life Sciences as Scientific Advisor


February 13, 2020

Sernova Achieves Positive Efficacy Endpoint in Phase I/II Clinical Trial for Type 1 Diabetes


February 10, 2020

Sernova Announces Positive DSMB Review and Recommendation for Continuation of Phase I/II Diabetes Clinical Trial of Cell Pouch™


December 18, 2019

Motif Labs secures additional growth financing and announces extraction agreement with cultivator JC Green


November 06, 2019

Comet Bio Achieves Self-Affirmed GRAS Status for its PREbiotic Arabinoxylan Plant Fiber Extract, Arrabina™


November 01, 2019

Announcement: Acting Chief Administrative Officer appointment


October 15, 2019

A novel system to modulate the composition of the microbiome


October 10, 2019

Comet Bio Launches Upcycled Arabinoxylan PREbiotic Dietary Fiber ahead of SupplySide West


March 18, 2021

CARL revolutionizing audiology education


September 10, 2019

Sernova Completes Oversubscribed Private Placement of $4,684,564


September 10, 2019

ENDRA Life Sciences to Showcase TAEUS(TM) Liver Application at the EASL Non-Alcoholic Fatty Liver Disease Summit in Seville, Spain on September 26-28, 2019


August 07, 2019

TechAlliance Welcomes Christina Fox as CEO


June 27, 2019

Sernova’s Principal Investigator to Present Interim Data from the Company’s Ongoing Phase I/II Cell Pouch Clinical Trial at the 17th World Congress of the International Pancreas and Islet Transplant Association


June 09, 2019

Second cannabis company puts down roots in Aylmer facility


June 03, 2019

Comet Bio Sweeterra™ Syrups Win Institute of Food Technologists 2019 Innovation Award


May 21, 2019

Sernova Corp Announces Appointment of Deborah Brown to its Board of Directors


April 23, 2019

Renix Successfully Commissions the Demonstration RenixUIX™ Unit


April 16, 2019

Western Medical Innovation Fellows awarded two BURST funds


February 11, 2019

Sernova Corp Announces First Patient Implanted with Sernova’s Cell Pouch™ in a Phase I/II US Clinical Trial for the Treatment of Hypoglycemia Unawareness in Subjects with Type 1 Diabetes


March 18, 2021

Sernova Announces Biotech Veteran as New Chief Financial Officer


October 16, 2019

Sernova Confirms Enduring Levels of Fasting C-Peptide in Bloodstream of First Patient in its Phase I/II Clinical Trial for Type-1 Diabetes


February 04, 2019

SWO Angels Investee, Topspin Technologies, Wins NFL’s First and Future Prize


January 31, 2019

Ivey Publishing Announces Best-Selling Cases of January 2019


January 30, 2019

Sernova Announces the Appointment of Dr. David Lillicrap, M.D. to its Scientific Advisory Board


January 17, 2019

Sernova Announces Successful Enrollment Approaching 50% of Subjects in its U.S. Phase I/II Cell Pouch Diabetes Clinical Trial